The autologous mixed-lymphocyte reactions (AMLR) of peripheral blood lymphocytes from 80 patients with adult periodontitis were examined. Some but not all patients showed clearly low AMLR responses; 31 of 80 subjects (39%) showing consistently low responses in AMLR (less than the mean -2 standard deviations of the healthy control group values) were designated low-AMLR patients, whereas the 42 patients (53%) who showed normal AMLR responses were designated normal-AMLR patients. However, there were no significant differences in the clinical parameters between these two groups of patients. The phenotypic analysis of T-cell fractions revealed a lower percentage of CD45RA-positive cells in CD4-positive cells (CD4+ CD45RA+ T cells) in the low-AMLR patients than those in normal-AMLR patients and healthy control subjects. No significant differences were demonstrated between the two groups in terms of the proportion of CD4-positive and CD8-positive cells in the T-cell fractions or in the expression of human leukocyte antigen DR of the monocytes and B cells in the non-T-cell fractions. In the low-AMLR patients, the allogeneic MLR was found to be normal, but the interleukin 2 production in the AMLR was found to be significantly depressed. The depressed AMLR responses and the lower percentage of CD4+ CD45RA+ T cells in the low-AMLR patients were found to be normalized following the periodontal therapy. These results might reflect changes in regulatory T-cell function induced by development of periodontal diseases.
Immunological mechanisms have been implicated in the pathogenesis of human periodontal diseases. Advanced periodontitis is recognized as a B-cell-rich lesion that includes immunoglobulin G-producing plasma cells (14) . However, it has been reported that not a few T cells were also present subjacent to the pocket epithelium in conjunction with the plasma cells (21, 31) . Our previous study revealed that the proportion of CD4-positive (CD4+) T cells decreased and that the proportion of CD8-positive (CD8+) T cells increased in the inflamed human gingiva (20) . These histopathological findings suggested that periodontal lesions might be induced by the immunoregulatory imbalance of T cells, since T cells and T-cell-derived factors have been recognized to play a central role in the immunoregulatory network at both local and systemic levels.
The autologous mixed-lymphocyte reaction (AMLR), which represents an immunologic response of the T-cell reaction to surface major histocompatibility complex class II antigens expressed on non-T cells, has been thought to reflect an autoregulatory immune mechanism (10, 22) . In several studies of subjects with periodontal diseases, the spontaneous proliferative response (SPR), as a measure of AMLR, of peripheral blood lymphocytes has been demonstrated. These reports have shown the depression of the SPR in young subjects with advanced periodontitis (41) and generalized juvenile periodontitis (35) and in both young and older subjects with periodontal diseases (3) . However, the nature of the AMLR in periodontal diseases is still poorly understood and undefined.
The present study was designed to examine further the nature of AMLR in adult periodontitis and any phenotypic and functional alterations in the peripheral blood monocytes and lymphocytes in these patients. The phenotypic analyses * Corresponding author.
were performed in both responder and stimulator fractions in the AMLR by means of the direct immunofluorescence technique using antibodies to CD36, human lymphocyte antigen DR (HLA-DR), CD4, CD8, and CD45RA. To characterize the functional alterations, interleukin 2 (IL-2) production in AMLR and allogeneic MLR was evaluated by using the lymphocytes from the same patient population.
MATERIALS AND METHODS
Subjects. The 80 participating patients (mean age, 37.1 ± 0.9 years), 40 men and 40 women, suffering from adult periodontitis were selected from the Osaka University Dental Hospital. All patients completed medical and dental histories and had thorough clinical and radiographic dental examinations. On the basis of these findings, the patients had been assigned a diagnosis of adult periodontitis by using previously published criteria (24) . As the clinical parameters, gingival index (13), plaque index (32), the percentage of alveolar bone destruction (30) , and the number of affected teeth showing more than 30% bone loss on radiographs (11) were recorded. Following subject selection with a screening examination, each participant was given plaque control instructions and supra-and subgingival scaling and root planing as the initial periodontal treatment and received flap surgery with or without osseous reductions. The 
RESULTS
The distribution of the AMLR responses of the patients is illustrated in Fig. 1 . Compared with the control subjects, different individual periodontitis patients gave various AMLR responses, ranging from 51 to 59,485 dpm, although the mean AMLR response of the patients (17,607 + 1,428 dpm, mean ± SEM) was significantly lower than that of the control (24,980 ± 1,332 dpm) (P < 0.05).
In the patient group, it was found that some subjects showed significantly low AMLR responses, whereas some of the healthy control group) were designated low-AMLR patients in this study, whereas the 42 patients (53%) who showed normal AMLR responses (from mean -2 SD to mean +2 SD of the healthy control group) were designated normal-AMLR patients.
The kinetics of the AMLR responses revealed that the peak AMLR responses in low-and normal-AMLR patients occurred coincidentally, showing an increase from day 5 to a peak at day 7, followed by a decrease through day 9 to day 11 ( Fig. 2) .
The mean age and the clinical parameters, including the mean probing pocket depth, gingival index, plaque index, mean percentage of alveolar bone loss, and percentage of the teeth affected (teeth with >30% bone loss), of the low-and normal-AMLR patients before periodontal treatment are shown in Table 1 . The statistical analysis by mean age and the clinical parameters used in this study revealed no significant differences between low-and normal-AMLR patients. Furthermore, no significant correlation was found between AMLR and any clinical parameter in either patient group (data not shown).
To determine whether the AMLR response of the individual patient changes along with the conventional periodontal treatment, we examined the AMLR responses of both lowand normal-AMLR patients just after the initial periodontal Incubation time (days)
Kinetics of the AMLR responses of low-and normal-AMLR patients. T-cell and MMC-pretreated non-T-cell fractions from low-AMLR patients (0), normal-AMLR patients (0), and healthy control subjects (CI) were incubated for 3 to 11 days. All cultures were pulse-labelled with 3H-TdR 20 h before harvest, and the AMLR was expressed as the net 3H-TdR uptake. treatment and in the maintenance phase (6 months after the initial periodontal treatment) (Fig. 3) . In low-AMLR patients, the AMLR response increased after the initial periodontal treatment and reached appreciable normal levels at the maintenance-phase examination. In contrast, the AMLR response of normal-AMLR patients remained unchanged. However, the periodontal treatment resulted in significant improvements of the clinical parameters in both low-and normal-AMLR patients (Fig. 4) .
The phenotypic analyses of non-T-cell and T-cell fractions from both low-and normal-AMLR patients as well as those from healthy controls are summarized in Tables 2 and 3, respectively. In the studies with the non-T-cell fraction, no significant differences were observed in terms of the expression of HLA-DR on the monocytes (CD36-positive HLA-DR-positive [CD36+ HLA-DR+] cells) and B cells (CD36-HLA-DR+ cells) among the three groups.
On the other hand, the phenotypic analysis of the T-cell fraction revealed that the percentage of CD45RA-positive cells in CD4-positive cells (CD4+ CD45RA+ T cells) in low-AMLR patients (23.3 + 2.3%) was significantly lower than that in normal-AMLR patients (33.3 + 3.4%; P < 0.05) and healthy control subjects (35.6 2.5%; P < 0.05). There were no significant differences in the percentages of CD4-positive and CD8-positive cells or in the CD4/CD8 cell ratio between low-and normal-AMLR patients. A typical staining (0) were examined just after the initial periodontal treatment and during the maintenance phase (6 months after the initial periodontal treatment). The phenotypic analysis of the peripheral blood mononuclear cells was also carried out, and the changes during the periodontal treatments in the percentages of CD4+ CD45RA+ T cells in the low-AMLR patients (U) and normal-AMLR patients (O) are illustrated. Before treatment, a significantly lower AMLR response (*; P < 0.01) and percentage of CD4+ CD45RA+ T cells (**; P < 0.05) was observed in low-AMLR patients than that in normal-AMLR patients.
profile of the T-cell fraction from a low-AMLR patient and a normal-AMLR patient is displayed in Fig. 5 . All of the results for the normal-AMLR patients shown in Tables 2 and  3 were not significantly different from those of health: control subjects.
The percentages of CD4+ CD45RA+ T cells varied along with the periodontal treatment in a manner similar to AMLR responses in either patient group. Figure 3 also illustrates the changes with the periodontal treatment in the percentages of CD4+ CD45RA+ T cells of low-and normal-AMLR patients. In low-AMLR patients, the percentage of CD4+ CD45RA+ T cells increased and reached normal levels during the periodontal treatment, whereas the percentage of CD4+ CD45RA+ T cells in normal-AMLR patients did not change essentially until the maintenance phase.
Since earlier studies suggested that in the course of AMLR, CD4+ cells could produce IL-2, a finding which supports the proliferative response of CD4+ cells and probably CD8+ cells as well (26, 33, 37) , we next determined whether the low AMLR response in the low-AMLR patients a Values given are means ± SEM. b Significantly lower response than those in normal-AMLR patients and in healthy controls (P < 0.01).
was associated with the diminished production of IL-2 in AMLR. Table 4 shows the mean IL-2 activities of day 3 AMLR culture supernatants from low-and normal-AMLR patients. On the basis of this assay, only low-AMLR patients revealed low levels of IL-2 production; normal-AMLR patients and healthy controls showed normal IL-2 production in AMLR. Allogeneic MLR of the T-cell fraction from low-and normal-AMLR patients were conducted by using the non-Tcell fractions from the healthy control subjects (Fig. 6) . In contrast to AMLR, the T-cell fraction from both low-and normal-AMLR patients had normal allogeneic MLR.
DISCUSSION
The results demonstrated that the peripheral blood lymphocytes of some of the patients with adult periodontitis showed consistently low AMLR responses. Although the peripheral blood lymphocyte fractions from the same individual were collected on several different days and at different times of the day in preliminary experiments, the AMLR response of an individual subject was found to be essentially consistent. Moreover, kinetic studies of AMLR revealed that peak responses occurred coincidentally. Therefore, we further examined the nature of AMLR, comparing low-AMLR patients to the normal-AMLR patients and healthy controls. Similar observations with AMLR responses of peripheral blood lymphocytes were reported in the studies with Sjogren's syndrome (15, 29) , Hodgkin's disease (7), acute infectious mononucleosis (16) , and chronic active liver diseases (42) . In these diseases, it was demonstrated that some but not all patients showed significantly low AMLR responses. In systemic lupus erythematosus (SLE), it was reported that the patients with active SLE showed markedly diminished AMLR responses, whereas the patients with inactive SLE showed a slight reduction in AMLR responses (1, 9, 28, 34) .
In periodontal diseases, by using SPR as a measure of AMLR in most studies, the depression of the SPR was demonstrated in some types of periodontal diseases although the abnormalities in AMLR in relation to the types of periodontal diseases were still controversial. Tew In all of these studies, however, the distribution of individual AMLR responses was not clear and the phenotypic and/or functional alterations in the peripheral blood mononuclear cells in relation to AMLR responses were undefined. Therefore, the nature of AMLR in periodontal disease is still poorly understood. In this study, we examined the distribution of AMLR responses in 80 adult periodontitis patients and found that some but not all patients showed low AMLR responses. Since the patients in both groups were clinically diagnosed with adult periodontitis, it was not surprising that there were no significant differences in the mean age and the clinical parameters between low-and normal-AMLR patients.
The present results, however, indicated that periodontal treatment had modulated the AMLR responses in low-AMLR patients but not in normal-AMLR patients, although significant improvements in the clinical parameters were observed in both patient groups. The AMLR response in the low-AMLR patients increased after the initial periodontal treatment, and it appeared to restore normal responsiveness through the maintenance phase (Fig. 3) . These findings are in accordance with the results of Tew et al. (41) and Osterberg et al. (23) , who found that the SPR was increased to normal levels following the completion of the periodontal treatments. It should be mentioned here that Evans et al. (8) reported that a complete return to normal levels of SPR did not occur immediately after the initial periodontal treatment. Since AMLR has been suggested to be a possible indicator of immunoregulation in inflammatory diseases, the depressed AMLR responses in the low-AMLR patients might reflect changes in regulatory T-cell function induced by some state(s) of the periodontal diseases.
The AMLR is a proliferative response of T cells stimulated in vitro by autologous non-T cells in the absence of any antigen, although the immunological mechanisms have not yet been completely defined. In the AMLR, T cells are The mean probing pocket depth, gingival index, and plaque index of both low-AMLR patients (A, 0, and O, respectively) and normal-AMLR patients (A, 0, and *, respectively) were examined just after the initial periodontal treatment and during the maintenance phase. During the periodontal treatments, significant improvements in all the clinical parameters tested were observed in both low-and normal-AMLR patients. However, no significant differences were found between the two patient groups with respect to any clinical parameter.
induced to proliferate by major histocompatibility complex class II antigens (HLA-DR) presented by non-T cells, mainly monocytes and B cells (2, 6, 12, 25) . Phenotypically, no significant differences in the expression of HLA-DR in monocytes and B cells between the two patient groups were observed (Table 2) . Therefore, it is unlikely that low AMLR responses could be attributable to an alteration in the expression of the major histocompatibility complex class II antigens on the non-T-cell fraction in the low-AMLR patients.
Recently, it has become evident that the CD4+ lymphocytes can be further subdivided into functionally and phenotypically distinct populations of cells on the basis of their expression of CD45RA (18, 27, 38) . The CD4+ CD45RA+ cells have been demonstrated to proliferate preferentially in response to autologous non-T cells (17, 39) . It was also demonstrated that CD4+ CD45RA-cells as well as CD4+ c Significantly lower than those in normal-AMLR patients and in healthy controls (P < 0.05).
d Significantly lower than those in normal-AMLR patients and in healthy controls (P < 0.01). CD45RA+ cells could proliferate in response to allogeneic non-T cells (17, 18) . In the present study, the phenotypic analysis of the T-cell fraction revealed that the percentage of CD4+ CD45RA+ T cells in low-AMLR patients was significantly lower than those in normal-AMLR patients and healthy control subjects. Furthermore, the allogeneic MLR of the T-cell fraction from low-AMLR patients was found to be normal (Fig. 6 ). The present findings on the phenotypic analysis of the T-cell fraction and the results in the allogeneic MLR in low-AMLR patients are in accordance with the results presented by Morimoto and coworkers (17, 18, 39) and strongly suggested that the low responsiveness in low-AMLR patients could be attributable to the reduction in the percentage of the CD4+ CD45RA+ T-cell population.
Recent studies regarding CD4+ subsets defined with anti-CD45RA monoclonal antibody have revealed that CD4+ CD45RA-cells exhibit a "memory" proliferative response to soluble recall antigen and provide help for antibody (4, 40) . In this study, the percentages of CD4+ CD45RA+ T cells as well as the AMLR response increased during the periodontal treatment in low-AMLR patients. A likely explanation for this finding may be that before treatment CD4+ cells were actively differentiating into memory cell populations by the continuous stimulation of the local periodontopathic antigens and that the periodontal treatment decreased active stimulation, resulting in the gradual restoration of CD4+ CD45RA+ subsets to normal levels. However, further experiments will be required, since 42 of 80 patients with adult periodontitis in this study showed consistently normal AMLR responses and percentages of CD4+ CD45RA+ cells before and after periodontal treatments.
Low levels of IL-2 production in the AMLR were found only in low-AMLR patients (Table 4) . Earlier studies demonstrated that CD4+ cells could produce IL-2, which may support T-cell proliferation in the AMLR (25, 26, 33, 37, 42) . However, Suzuki et al. (36) suggested that IL-3 but not IL-2 could induce proliferation of the responder cells in the AMLR. The present finding with IL-2 production in AMLR is in accordance with the results reported by Oen et al. (19) . They found that some patients with juvenile rheumatoid arthritis had both a low AMLR and low levels of IL-2 production in the AMLR and suggested that the reduction of AMLR in these patients might be due to a decrease in IL-2 production and a decreased responsiveness to IL-2 as well. Takada et al. (37) also demonstrated depressed IL-2 production in the patients with SLE who showed low AMLR responses. Since CD4+ CD45RA+ cells have been demonstrated to proliferate preferentially in response to autologous non-T cells, it is likely that CD4+ CD45RA+ cells mainly produce IL-2 in the AMLR, which in turn induces proliferation of the cells responding to the factor. However, further studies will be required, since the possibility that IL-2 production was normal but was consumed in low-AMLR patients was not ruled out in this study.
